Anti-angiogenic and molecularly targeted therapy for advanced or metastatic renal cell carcinomaThe content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care...
Cell-free methylated DNA immunoprecipitation and high-throughput sequencing (cfMeDIP–seq) is a highly sensitive assay capable of detecting early-stage tumors. We report accurate classification of patients across all stages of renal cell carcinoma (RCC) in plasma (area under the receiver operating ...
This study was conducted to evaluate the efficacy of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib with pegylated-IFNα (PEG-IFNα) in patients with advanced renal cell carcinoma. Methods Progression-free survival (PFS) rate at 6 months >50% was considered promising for ...
Motzer, R.J., Robbins, P.B., Powles, T.et al.Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial.Nat Med26, 1733–1741 (2020). https://doi.org/10.1038/s41591-020-1044-8 ...
nephropathy; TLCO: twelve-layer concentric objects; RAS: renal artery stenosis; ROI: region of interest; ccRCC: clear-cell renal cell carcinoma; D: diffusivity; D*: pseudo-diffusivity; f: perfusion fraction; FA: fraction anisotropy; MFAML: minimal-fat angiomyolipoma; RCC: renal cell carcinoma....
UpToDate. Patient education: Renal cell carcinoma (kidney cancer) (Beyond the Basics).. Last accessed September 23, 2021.
In: Quaia E, editor. 2011 radiological imaging of the kidney. Berlin: Springer; 2011. p. 595–604.Hines-Peralta A, Goldberg S. Radiofrequency ablation and cryoa- blation for renal cell carcinoma. In: Atkins M, Dizon D, editors. UptoDate. Waltham, MA: Wolters Kluwer Health; 2013....
Renal cell carcinomaUrologic malignancymicroRNAsKidney diseaseIn the present review, we have summarized the uptodate preliminary clinical works on the role of urinary miRNA profiling in RCC, including an evaluation of its value as a potential biomarker for diagnosis, prognosis and follow up of RCC ...